Loading market data...
Latest Top News
Show more
Medicamen Biotech Approves Major Capital Raise via Allotment of Shares and Warrants at ₹530 Each
Medicamen Biotech Ltd has announced a significant capital infusion through the preferential allotment of equity shares and fully convertible warrants, both priced at ₹530 each, as approved by its Board of Directors on February 26, 2025.
Key Highlights:
The Board approved th...
Stay Ahead – Explore Now! AC-ting Cool: Sharp Returns to India With A Blast Of Cool Air!






